Before reconstitution Lyophilized powder storage: Room temperature: Fine for months Refrigerator (2-8C): Extends shelf life to 12-24 months Freezer (-20C): Maximum shelf life (24-36 months) Keep in original packaging, protect from light Don't: Leave in hot car Expose to direct sunlight Open vial until ready to reconstitute Get moisture inside vial After reconstitution Critical: Refrigerate immediately: Store at 2-8C (36-46F) Main fridge section, not door (too much temperature fluctuation) Use within 28-30 days maximum Discard if cloudy or discolored Daily use: Remove from fridge briefly to draw dose Return to fridge immediately Don't leave out for hours Each removal should be 5 years continuous use) When to stop and consult physician: Severe or persistent side effects Allergic reaction (rash, difficulty breathing) Unexpected symptoms Contraindications Avoid BPC-157 if: Pregnant or breastfeeding (no safety data) Active cancer (theoretical tumor growth concern) Severe allergic reaction to previous dose Use caution if: Taking blood thinners (BPC-157 may affect coagulation) Scheduled for surgery (stop 1-2 weeks before) Significant health conditions (consult physician) See our peptide safety and risks guide
This dose has been extensively studied in combination with semaglutide under the investigational name CagriSema, achieving up to 22.7% weight reduction at 68 weeks in phase 3 trials [4]
The clearance rates indicated above were within the published ranges for these often employed standards (Di 2003, Shou 2005, Lu 2006, Behera 2008)
As a new type of topical dosage form, it significantly accelerates the healing of burns, trauma, diabetic ulcers and inflammatory bowel disease through multiple mechanisms such as promoting angiogenesis, inhibiting inflammatory responses, accelerating cell proliferation and antioxidation and antiapoptosis
15 spines for the vehicle
Research-only labelling: All legitimate research peptide products must carry unambiguous research-use-only designations with no therapeutic, clinical, or health claims
